AI assistant
Medtronic plc — Director's Dealing 2016
Sep 19, 2016
29841_dirs_2016-09-19_60c9ff4e-d0c4-4f0b-95ea-30ec68312a33.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2016-09-15
Reporting Person: Powell Kendall J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-09-15 | Ordinary Shares | M | 2977 | $51.61 | Acquired | 27198 | Direct |
| 2016-09-15 | Ordinary Shares | M | 1010 | $52.84 | Acquired | 28208 | Direct |
| 2016-09-15 | Ordinary Shares | M | 1590 | $50.34 | Acquired | 29798 | Direct |
| 2016-09-15 | Ordinary Shares | M | 2671 | $29.96 | Acquired | 32469 | Direct |
| 2016-09-15 | Ordinary Shares | M | 1813 | $44.13 | Acquired | 34282 | Direct |
| 2016-09-15 | Ordinary Shares | S | 7907 | $85.445 | Disposed | 26375 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-09-15 | Stock Option (Right to Buy) | $51.61 | M | 2977 | Disposed | 2017-06-22 | Ordinary Shares (2977) | Direct |
| 2016-09-15 | Stock Option (Right to Buy) | $52.84 | M | 1010 | Disposed | 2017-09-01 | Ordinary Shares (1010) | Direct |
| 2016-09-15 | Stock Option (Right to Buy) | $50.34 | M | 1590 | Disposed | 2018-04-28 | Ordinary Shares (1590) | Direct |
| 2016-09-15 | Stock Option (Right to Buy) | $29.96 | M | 2671 | Disposed | 2019-04-27 | Ordinary Shares (2671) | Direct |
| 2016-09-15 | Stock Option (Right to Buy) | $44.13 | M | 1813 | Disposed | 2020-05-03 | Ordinary Shares (1813) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 3000 | Indirect |
Footnotes
F1: This balance increased by 110 shares due to exempt transactions such as dividend reinvestment.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.433 to $85.453, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: This option to purchase 2,713 New Medtronic ordinary shares for $51.61 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,713 Medtronic common stock shares for $51.61 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
F4: This option to purchase 264 New Medtronic ordinary shares for $51.61 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 264 Medtronic common stock shares for $51.61 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
F5: This option to purchase 1,010 New Medtronic ordinary shares for $52.84 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,010 Medtronic common stock shares for $52.84 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
F6: This option to purchase 1,590 New Medtronic ordinary shares for $50.34 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,590 Medtronic common stock shares for $50.34 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
F7: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
F8: This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.